H. L. Weiner et al., Double-Blind Pilot Trial of Oral Tolerization with Myelin Antigens in Multiple Sclerosis Science 259, 1321-1324 (1993). |
Current Practice in Therapeutic Plasmapheresis Proceedings of two symposia held at the 17th International Congress of Internal Medicine, Kyoto, Oct. 11, and 12, pp. 158-177 (1984). |
Plasma Exchange Therapy in Neurological Disorders: A Clinician's Overview, Therapeutic Hemapheresis II pp. 27-54 CRC Press, 1985. |
Apheresis in the Treatment of Neurological Diseases, Therapeutic Apheresis Chapter 4, pp. 35-58 (1983), American Association of Blood Banks. |
W. G. Honer et al., Characterization of a Synaptic Antigen of Interest in Neuropsychiatric Illness Biol. Psychiatry 31, 147-158 (1992). |
D. W. Choi, Glutamate Neurotoxicity and Diseases of the Nervous System Neuron 1(8)623-634, 1988. |
J. O. McNamara and Inwin Fridovich, Did Radicals Strike Lou Gehrig Nature, pp. 20-22 (1993). |
R. Dingledine et al., Excitatory amino acid receptors in epilepsy TIPS 11, pp. 334-338 (1990). |
G. P. Gasic and Michael Hollmann, Molecular Neurobiology of Glutamate Receptors Annu. Rev. Physiol. 54, 507-536 (1992). |
M. Barinaga; Antibodies Linked to Rare Epilepsy, Science 268, pp. 362-363 (21 Apr. 1995). |
R. E. Twyman et al; Glutamate Receptor Antibodies Activate a Subset of Receptors and Reveal on Agonist Binding Site, Neuron 14, pp. 755-762 (Apr. 1995). |
Gorman et al., "Humanisation of monoclonal antibodies for therapy" Immunology, vol. 2 pp. 457-466 (1990). |
Rogers S. W. et al. "Autoantibodies to Glutamate Receptor GluR3 in Rasmussen's Encephalitis". Science 265:648-651, 1994. |
Ettlinger, G. and Lowrie, M. B. "An Immunological Factor in Epilepsy," The Lancet (i) 1386, 1977. |
Piatt J. H. et al. "Chronic Focal Encephalitis (Rasamussen Syndrome): Six Cases". Epilepsia 29(3) 268-279, 1988. |
Bouma, P. A. D. "Determining the Prognosis of Childhood Epilepsy by Establishing Immune Abnormalities," Clinical Neurology and Neurosurgery 94 (Suppl.): 554-556, 1992. |